“The interplay between oat beta glucan, gut microbiota and gut-liver axis in treatment of obesity associated non-alcoholic steatohepatitis and Type II diabetes mellitus”, IJBB, vol. 59, no. 1, pp. 14–22, Jun. 2023, doi: 10.56042/ijbb.v59i1.55932.